• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有间质水平缓慢流动的微流体平台中重建神经毒性淀粉样β寡聚体组装体。

Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow.

作者信息

Choi Yoon Jung, Chae Sukyung, Kim Jeong Hun, Barald Kate F, Park Joong Yull, Lee Sang-Hoon

机构信息

Department of Biomedical Engineering, College of Health Science, Korea University, Seoul, Republic of Korea.

出版信息

Sci Rep. 2013;3:1921. doi: 10.1038/srep01921.

DOI:10.1038/srep01921
PMID:23719665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3667571/
Abstract

Alzheimer's disease is accompanied by progressive, time-dependent changes of three moieties of amyloid beta. In vitro models therefore should provide same conditions for more physiologic studies. Here we observed changes in the number of fibrils over time and studied the correlation between amyloid beta moieties and neurotoxicity. Although the number of fibrils increased dramatically, the change in neurotoxicity with time was small, suggesting that fibrils make little contribution to neurotoxicity. To study the neurotoxicity of diffusible moieties by regulating microenvironments, we created a bio-mimetic microfluidic system generating spatial gradients of diffusible oligomeric assemblies and assessed their effects on cultured neurons. We found amyloid beta exposure produced an atrophy effect and observed neurite extension during the differentiation of neural progenitor cells increased when cells were cultured with continuous flow. The results demonstrate the potential neurotoxicity of oligomeric assemblies and establish a prospective microfluidic platform for studying the neurotoxicity of amyloid beta.

摘要

阿尔茨海默病伴随着β淀粉样蛋白三个部分的渐进性、时间依赖性变化。因此,体外模型应为更具生理学意义的研究提供相同条件。在此,我们观察了原纤维数量随时间的变化,并研究了β淀粉样蛋白各部分与神经毒性之间的相关性。尽管原纤维数量急剧增加,但神经毒性随时间的变化很小,这表明原纤维对神经毒性的贡献很小。为了通过调节微环境来研究可扩散部分的神经毒性,我们创建了一个仿生微流控系统,该系统可产生可扩散寡聚体组装体的空间梯度,并评估它们对培养神经元的影响。我们发现β淀粉样蛋白暴露会产生萎缩效应,并观察到当神经祖细胞在连续流动条件下培养时,其分化过程中的神经突延伸增加。这些结果证明了寡聚体组装体潜在的神经毒性,并建立了一个用于研究β淀粉样蛋白神经毒性的前瞻性微流控平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/d6dfe678e4b7/srep01921-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/17a5cc0a9b35/srep01921-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/ca5a745e189c/srep01921-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/d6dfe678e4b7/srep01921-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/17a5cc0a9b35/srep01921-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/ca5a745e189c/srep01921-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3210/3667571/d6dfe678e4b7/srep01921-f4.jpg

相似文献

1
Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow.在具有间质水平缓慢流动的微流体平台中重建神经毒性淀粉样β寡聚体组装体。
Sci Rep. 2013;3:1921. doi: 10.1038/srep01921.
2
Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death.淀粉样β肽1-42的寡聚体和纤维状聚集体的神经毒性作用:内质网钙释放参与寡聚体诱导的细胞死亡。
Neuroscience. 2008 Aug 26;155(3):725-37. doi: 10.1016/j.neuroscience.2008.06.036. Epub 2008 Jun 19.
3
Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity.壳寡糖保护大鼠原代海马神经元免受寡聚β-淀粉样蛋白 1-42 诱导的神经毒性。
Neurosci Lett. 2013 Oct 25;554:64-9. doi: 10.1016/j.neulet.2013.08.046. Epub 2013 Aug 30.
4
Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity.β-淀粉样肽的酰胺化显著降低了淀粉样生成活性,而不改变神经毒性。
J Neurochem. 1997 Nov;69(5):2048-54. doi: 10.1046/j.1471-4159.1997.69052048.x.
5
ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.载脂蛋白E可保护皮质神经元免受由β-淀粉样肽非纤维状C末端结构域诱导的神经毒性作用。
J Neurochem. 2001 Jan;76(1):117-27. doi: 10.1046/j.1471-4159.2001.00047.x.
6
Membrane-bound tetramer and trimer Aβ oligomeric species correlate with toxicity towards cultured neurons.膜结合四聚体和三聚体Aβ寡聚体与对培养神经元的毒性相关。
J Neurochem. 2016 Feb;136(3):594-608. doi: 10.1111/jnc.13443.
7
Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.淀粉样β的无毒构象可能会抑制淀粉样β诱导的大鼠原代神经元毒性:这对于阿尔茨海默病的新型治疗策略具有重要意义。
Biochem Biophys Res Commun. 2013 Aug 16;438(1):1-5. doi: 10.1016/j.bbrc.2013.05.106. Epub 2013 Jun 4.
8
Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.壳寡糖抑制/分解原纤维并减轻淀粉样β介导的神经毒性。
Int J Mol Sci. 2015 May 8;16(5):10526-36. doi: 10.3390/ijms160510526.
9
Size-dependent neurotoxicity of beta-amyloid oligomers.β-淀粉样寡聚物的尺寸依赖性神经毒性。
Arch Biochem Biophys. 2010 Apr 15;496(2):84-92. doi: 10.1016/j.abb.2010.02.001. Epub 2010 Feb 11.
10
Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.阿尔茨海默病β-淀粉样蛋白神经毒性淀粉样纤维中间态中纤维状β-折叠结构的证据。
Nat Struct Mol Biol. 2007 Dec;14(12):1157-64. doi: 10.1038/nsmb1345.

引用本文的文献

1
Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics-Part A: Endogenous Compounds and Repurposed Drugs.β-淀粉样蛋白的小分子抑制剂:分子动力学的见解 - A部分:内源性化合物和重新利用的药物
Pharmaceuticals (Basel). 2025 Feb 23;18(3):306. doi: 10.3390/ph18030306.
2
Brain organoids: A new tool for modelling of neurodevelopmental disorders.脑类器官:神经发育障碍建模的新工具。
J Cell Mol Med. 2024 Sep;28(17):e18560. doi: 10.1111/jcmm.18560.
3
Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype.

本文引用的文献

1
Size-controllable networked neurospheres as a 3D neuronal tissue model for Alzheimer's disease studies.可控制大小的网络化神经球作为阿尔茨海默病研究的 3D 神经元组织模型。
Biomaterials. 2013 Apr;34(12):2938-46. doi: 10.1016/j.biomaterials.2013.01.038. Epub 2013 Jan 29.
2
Amyloid-β forms fibrils by nucleated conformational conversion of oligomers.淀粉样蛋白-β通过寡聚物的成核构象转化形成原纤维。
Nat Chem Biol. 2011 Jul 31;7(9):602-9. doi: 10.1038/nchembio.624.
3
What drives amyloid molecules to assemble into oligomers and fibrils?是什么促使淀粉样蛋白分子组装成寡聚物和原纤维?
淀粉样β模拟肽水凝胶基质对神经前体细胞表型的影响。
Acta Biomater. 2024 Jul 15;183:89-100. doi: 10.1016/j.actbio.2024.05.020. Epub 2024 May 25.
4
Neuropathogenesis-on-chips for neurodegenerative diseases.神经退行性疾病的类脑芯片研究进展
Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8.
5
Advances in current models on neurodegenerative diseases.当前神经退行性疾病模型的进展。
Front Bioeng Biotechnol. 2023 Nov 6;11:1260397. doi: 10.3389/fbioe.2023.1260397. eCollection 2023.
6
Amyloid-β slows cilia movement along the ventricle, impairs fluid flow, and exacerbates its neurotoxicity in explant culture.淀粉样蛋白-β会减缓脑室中的纤毛运动,阻碍液体流动,并在离体培养中加剧其神经毒性。
Sci Rep. 2023 Aug 21;13(1):13586. doi: 10.1038/s41598-023-40742-0.
7
Gut Microbiota and Alzheimer's Disease: How to Study and Apply Their Relationship.肠道微生物群与阿尔茨海默病:研究和应用它们之间关系的方法。
Int J Mol Sci. 2023 Feb 17;24(4):4047. doi: 10.3390/ijms24044047.
8
How Organ-on-a-Chip Technology Can Assist in Studying the Role of the Glymphatic System in Neurodegenerative Diseases.器官芯片技术如何帮助研究神经退行性疾病中糖脂代谢系统的作用
Int J Mol Sci. 2023 Jan 21;24(3):2171. doi: 10.3390/ijms24032171.
9
In Vitro 3D Modeling of Neurodegenerative Diseases.神经退行性疾病的体外3D建模
Bioengineering (Basel). 2023 Jan 10;10(1):93. doi: 10.3390/bioengineering10010093.
10
An Alzheimer's Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease.基于早期病理学、解剖学、血管诱导的血流、最大流应力能量位置迁移以及血管疾病增加的阿尔茨海默病机制。
J Alzheimers Dis. 2022;90(1):33-59. doi: 10.3233/JAD-220622.
Biophys J. 2011 Jan 19;100(2):450-8. doi: 10.1016/j.bpj.2010.11.041.
4
Regulating microenvironmental stimuli for stem cells and cancer cells using microsystems.利用微系统调控干细胞和癌细胞的微环境刺激。
Integr Biol (Camb). 2010 Jun;2(5-6):229-40. doi: 10.1039/c000442a. Epub 2010 Jun 8.
5
Alzheimer's disease amyloid beta-protein and synaptic function.阿尔茨海默病淀粉样β蛋白与突触功能。
Neuromolecular Med. 2010 Mar;12(1):13-26. doi: 10.1007/s12017-009-8091-0. Epub 2009 Sep 16.
6
Differentiation of neural progenitor cells in a microfluidic chip-generated cytokine gradient.在微流控芯片生成的细胞因子梯度中神经祖细胞的分化。
Stem Cells. 2009 Nov;27(11):2646-54. doi: 10.1002/stem.202.
7
Amyloid beta and APP as biomarkers for Alzheimer's disease.淀粉样β蛋白和 APP 作为阿尔茨海默病的生物标志物。
Exp Gerontol. 2010 Jan;45(1):23-9. doi: 10.1016/j.exger.2009.08.002. Epub 2009 Aug 19.
8
Gradient generation by an osmotic pump and the behavior of human mesenchymal stem cells under the fetal bovine serum concentration gradient.渗透泵产生的梯度以及人骨髓间充质干细胞在胎牛血清浓度梯度下的行为。
Lab Chip. 2007 Dec;7(12):1673-80. doi: 10.1039/b710777c. Epub 2007 Sep 6.
9
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology.脑间质液大量流动的证据:对生理学和病理学的意义
Neurochem Int. 2004 Sep;45(4):545-52. doi: 10.1016/j.neuint.2003.11.006.
10
Structural and functional aspects of the blood-brain barrier.血脑屏障的结构与功能方面
Prog Drug Res. 2003;61:39-78. doi: 10.1007/978-3-0348-8049-7_2.